CONFERENCE SERIES WIDENS INVESTOR ACCESS TO CUTTING-EDGE HEALTHCARE STOCKS

CONFERENCE SERIES WIDENS INVESTOR ACCESS
TO CUTTING-EDGE HEALTHCARE STOCKS

Edison Open House: Healthcare 2022 will connect new businesses to a diverse group of more than 200,000 investors through virtual and in-person networking. 

Broad range of global companies presenting, including Oxford BioMedica and Carmat, the producer of the world’s first artificial heart

London 24 January – Leading international equity research and investor relations consultancy Edison Group has today announced the lineup and themes for Edison Open House: Global Healthcare 2022.

The three-day event, in association with London Stock Exchange, global law firm Taylor Wessing and OpenExchange, will take place between 25^th-27^th January, focusing on 33 companies. Day one will feature businesses within pharmaceuticals & drug discovery, day two focuses on businesses adopting new approaches to hard-to-solve problems, while AI & technology will round off the event.

Fireside chats with CXOs will be hosted by Vivienne Parry MBE, the renowned BBC broadcaster, science author and journalist. The aim is to reveal the investment cases of some of the most compelling listed healthcare businesses in a way that makes the stocks accessible to all investors - from the most seasoned professional to individuals wanting their first insight into the sector.

Separate panels will see opinion formers providing insight into the most important trends and advances predicted for 2022, the outlook for healthcare equity financing and the hot topics in biopharma partnering. Meanwhile ‘The Open 100’, offers ten TED-style ten-minute talks from handpicked CEOs. 

Content will be available to stream from the 25^th Jan on Edison’s website and OpenExchange.tv. Attendance is free and anyone wanting to attend can sign up here:  https://www.edisongroup.com/edison-open-house-global-healthcare-2022/

The event is part of Edison’s far broader strategy to connect experts and CEOs with investors of all types - from the largest institutions to a broad range of smaller, hard-to-reach pools of capital including family offices, wealth managers and individual investors.

Edison’s content reaches more than 2 million readers a year, with Open House: Healthcare 2021 alone being seen by over 200,000 investors. Whilst the audience is global, it is particularly concentrated within the UK, US and Europe and, despite a focus on professionals, encompasses investors of all types.

According to Rachel Carroll, Edison’s US President and Managing Partner: ‘Covid has highlighted the important role of investors within healthcare. Reports of record levels of investment in 2020 into innovative companies is indicative of the growing interest in the sector.[1]

“And yet, it has never been more important go be on the front foot and to reach all available pools of capital. Every company needs a clear and compelling narrative in an over-saturated market. This event series creates an invaluable opportunity for Edison clients to be seen and heard by the most active and relevant investors within healthcare.

‘‘With record investment flows over the last couple years and a glut of new issuance, it has never been more important for healthcare entrepreneurs to establish mindshare and intelligently target the broadest potential pool of investment capital. Edison Open House invites you to engage with industry experts and investment specialists over a three-day program that is accessible to everyone in our network and supplemented by direct meeting opportunities for CXOs and professional investors. We appreciate the momentous support of our virtual series as we look forward to a busy calendar of events with clients and partners in 2022.”

Ross McNaughtonat Taylor Wessing said: "I can't recall a time when there has been more interest or opportunity in the healthcare sector, or when there has been as many dimensions for companies and investors to take into consideration.  As the pandemic continues to shine a light on the sector generally and as technological advances enabling both early diagnostics and personalised medicine continue apace, opportunities remain rife. Shifts in government policy, whether pricing or regulation of new products or otherwise, can have sudden and long-lasting impact upon the business model of entire sub-sectors. All of this means companies and their investors need to be ever more savvy about their business models and how they demonstrate their understanding of how to make use of market complexity ultimately to drive profitable revenue and growth.  As a leading law firm in this space, we are delighted to be supporting this key stage conference once again, which will touch upon all of these topics and offer companies and investors the opportunity further hone their approach for the year to come."

Chris Mayo, Head of Americas Primary Markets, London Stock Exchange said: “The pandemic has highlighted the vital importance of innovation in the healthcare sector. The London Stock Exchange is pleased to be supporting the Edison Open House Healthcare Event as an excellent way for companies to raise visibility of the sector and for investors to understand the latest trends. London continues to be a strong platform for life sciences businesses from all over the world to raise capital and create positive social and economic impact.”

Mark Loehr at OpenExchange said: “OpenExchange enables the vital interactions of corporate communications through its interoperable video technologies, customizable livestream broadcasting solutions, and concierge managed services. We created OETV to be a digital hub where the investment world’s most savvy minds and voices gather on a single online destination to provide unique financial analysis and insight on topical, thematic, and corporate content. We are thrilled to partner with Edison Group to help produce and present this vital content to a broad and invested audience because, as we like to say, “these are meetings that matter.”

https://www.edisongroup.com/edison-open-house-global-healthcare-2022/